Cited by 91Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal and yeast genetics research

Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates

Open access
Pfaller, M. A., Lockhart, S. R., Pujol, C., Swails-Wenger, J. A., Messer, S. A., Edmond, M. B., Jones, R. N., Wenzel, R. P. +1 more·1998·Journal of Clinical Microbiology

Abstract

In a survey of bloodstream infection (BSI) isolates across the continental United States, 162 Candida albicans isolates were fingerprinted with the species-specific probe Ca3 and the patterns were analyzed for relatedness with a computer-assisted system. The results demonstrate that particular BSI strains are more highly concentrated in particular geographic locales and that established BSI strains are endemic in some, but not all, hospitals in the study and undergo microevolution in hospital settings. The results, however, indicate no close genetic relationship among fluconazole-resistant BSI isolates in the collection, either from the same geographic locale or the same hospital. This study represents the first of three fingerprinting studies designed to analyze the origin, genetic relatedness, and drug resistance of Candida isolates responsible for BSI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.36.6.1518-1529.1998

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Epidemiological data suggest that the intensity of fluconazole use is driving the appearance of resistant isolates.

    “Epidemiological data suggest that the intensity of fluconazole use is driving the appearance of resistant isolates (Pfaller et al., 1998).”

    From The evolution of drug resistance in clinical isolates of Candida albicans. (2015) · cites this paper as Pfaller et al., 1998

  • The greatest concern for fluconazole resistance relates to C. glabrata, for which rates of resistance as high as 15% have been reported.

    “The greatest concern for fluconazole resistance relates to C. glabrata, for which rates of resistance as high as 15% have been reported [40].”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 38 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [15]Odds F. Candida and candidosis: a review and bibliography. London, United Kingdom: Bailliere Tindall; 1988. [Google Scholar]
  2. [35]Soll D R. DNA fingerprinting of Candida albicans. J Mycol Med. 1993;3:37–44. [Google Scholar]

Cited by

Sorted by citations

Authors
Pfaller, M. A., Lockhart, S. R., Pujol, C., Swails-Wenger, J. A., Messer, S. A., Edmond, M. B., Jones, R. N., Wenzel, R. P., & Soll, D. R.
Affiliations
  • <!--label omitted: 1-->Departments of Pathology1 and
  • University of Iowa (US)
  • Virginia Commonwealth University (US)
Venue
Journal of Clinical Microbiology
Published
1998-06
Volume
36
Issue
6
Pages
1518-1529
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2113338279
Cited by
91
References
38
Citations by year
2024: 1 · 2023: 1 · 2021: 1 · 2019: 1 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 3
FWCI
7.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (Z01AG000214, T32AG000214)
  • National Institute of Allergy and Infectious Diseases (AI-2392)
  • National Institute of Dental and Craniofacial Research (DE1058)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
Candida albicans, bloodstream infection, fluconazole resistance, microevolution, genetic relatedness, strain fingerprinting, species-specific probes, antifungal resistance
MeSH terms
Antifungal Agents, Candida albicans, Candidiasis, Cross Infection, DNA, Fungal, Drug Resistance, Microbial, Hospitals, Humans, Microbial Sensitivity Tests, Phylogeny, Species Specificity, United States, Fluconazole, DNA Fingerprinting, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review